Family Medicine · Oskaloosa, IA
NPI
1346621059
Since 2015
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1229 C Ave E
Oskaloosa, IA, 52577
Phone (641) 672-3100
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
583 services
Medicare patients, 2024
50
Average age 73
Drug cost, 2024
$1.4M
15,711 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Zacharjasz was code 99490 (chronic, principal, and transitional care management), 208 times for 26 patients. In total Mark Zacharjasz billed 583 services in 15 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 208 | 26 | $46.90 | $9,755 |
| 99454 E&M - Miscellaneous | Office | 139 | 20 | $34.76 | $4,832 |
| 99457 E&M - Miscellaneous | Office | 122 | 21 | $37.64 | $4,591 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 31 | 17 | $34.37 | $1,066 |
| 99453 E&M - Miscellaneous | Office | 19 | 19 | $13.74 | $261 |
| 99422 Office/Outpatient Services | Office | 16 | 15 | $20.19 | $323 |
By year: 2023 $1,873 for 48 services; 2024 $23K for 583 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Zacharjasz prescribed most often to Medicare patients was Omeprazole, with 724 prescriptions and refills. In total Mark Zacharjasz wrote 15,711 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 724 | 1,786 | 194 | $8,319 |
| Atorvastatin Calcium Generic | 685 | 1,723 | 173 | $5,230 |
| Levothyroxine Sodium Generic | 582 | 1,464 | 132 | $3,921 |
| Amlodipine Besylate Generic | 494 | 1,162 | 121 | $2,744 |
| Lisinopril Generic | 377 | 931 | 95 | $1,981 |
| Furosemide Generic | 363 | 647 | 90 | $1,180 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 329 | 330 | 64 | $7,273 |
| Metoprolol Succinate Generic | 289 | 749 | 79 | $2,987 |
| Losartan Potassium Generic | 289 | 752 | 80 | $2,300 |
| Rosuvastatin Calcium Generic | 262 | 701 | 67 | $3,281 |
| Eliquis Apixaban | 240 | 268 | 32 | $151K |
| Pregabalin Generic | 229 | 263 | 43 | $7,232 |
| Potassium Chloride Generic | 224 | 364 | 43 | $4,295 |
| Bupropion Xl Bupropion Hcl | 214 | 398 | 46 | $3,741 |
| Tramadol Hcl Generic | 204 | 210 | 43 | $1,550 |
Brand drugs: 1,942 claims; generic drugs: 13,695 claims; opioid claims: 886.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Zacharjasz $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.